| dc.contributor.author | Pomplun, Sebastian Johannes | |
| dc.date.accessioned | 2021-06-02T20:07:16Z | |
| dc.date.available | 2021-06-02T20:07:16Z | |
| dc.date.issued | 2021-02 | |
| dc.date.submitted | 2020-11 | |
| dc.identifier.issn | 2632-8682 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/130898 | |
| dc.description.abstract | Fighting COVID-19 with high affinity reagents: this review article summarizes the discovery of several classes of (bio) molecules targeting the SARS-CoV-2 spike protein. | en_US |
| dc.publisher | Royal Society of Chemistry (RSC) | en_US |
| dc.relation.isversionof | https://doi.org/10.1039/D0MD00385A | en_US |
| dc.rights | Creative Commons Attribution NonCommercial License 4.0 | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | en_US |
| dc.source | Royal Society of Chemistry (RSC) | en_US |
| dc.title | Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Pomplun, Sebastian. "Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides." RSC Medicinal Chemistry 12, 2 (February 2021): 197. © 2021 The Royal Society of Chemistry | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
| dc.relation.journal | RSC Medicinal Chemistry | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.date.submission | 2021-06-02T15:46:10Z | |
| mit.journal.volume | 12 | en_US |
| mit.journal.issue | 2 | en_US |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Complete | |
